��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2006, 32(4) 247-250 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��
	��״ϸ��
	��չ
	��
	��
	֣��
	PubMed
	Article by ZHAO Tian-en
	Article by ZHENG Jiarun

Ƥ��״ϸ��о��չ

��¹, ֣��²

1. ɽ��ʡƤ��Բ��о��, �� 250022;
2. �й�ҽѧ��ѧԺ��й�Э��ҽ�ƴ�ѧƤ��о��

ժҪ��

��Ϸ��,Ƥ��״ϸ��,��.��Ƥ��״ϸ��ٴ��֯��ѧ�ϵĶ��,��.�м��ڴ�,�Խ��й�Ƥ��״ϸ��ڻ��ٴ��о��չ,��в�ѧ��ͷ��ơ��ٴ��ͺͱ��֡��Ϻͼ��ϡ��µ��ƴ�ʩ��Ԥ��,��ڶ�Ƥ��״ϸ��ϡ��ѡ��Ԥ��.

�ؼ���� ״ϸ�� չ

Advances in the Research of Cutaneous Squamous Cell Carcinoma

Shandong Provincial Institute of Dermtovenereology, Jinan 250022, China

Abstract:

Cutaneous squamous cell carcinoma (CSCC) is one of the common malignant skin tumors.Recent data analyses reveal an increasing tendency in the incidence of CSCC,especially in the aged persons.Because of marked diversity in clinical and histopathological manifestations of CSCC,misdiagnosis often occurs.The current developments in basic and clinical investigations of CSCC,such as the epidemiology,etiology,pathogenesis,clinical types and manifestations,diagnosis and differential diagnosis,current management as well as prevention are reviewed,which may be beneficial to the early diagnosis,therapeutic options and prophylaxis of CSCC.

Keywords: Carcionoma,squamous cell Advances

�ո�� 2006-01-17 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Freedberg IM,Elsen AZ,Wolff K,et al.Dermatology in General Medicine,5th ed,New York:Mc Graw-Hill,1999.840-855.
[2] Hawrot A,Alam M,Ratner D.Squamous cell carcinoma.Curr Probl Dermatol,2003,15:85-134.
[3] Clark C.Non-melanoma skin cancer:past,present and future.Curr Probl Dermatol,2001,13:109.
[4] Sander CS,Chang H,Hamm F,et al.Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis.Int J Dermatol,2004,43:326-335.
[5] Purdie K J,Surentheran T,Sterling JC,et al.Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals.J Invest Dermatol,2005,125:98-107.
[6] Harwood CA,Surentheran T,Sasieni P,et al.Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.Br J Dermatol,2004,150:949-957.
[7] Odom RB,James WD,Berger TG,et al.Andrews's Diseases of the Skin.9th ed,New York:Saunders,2000.832-836.
[8] Chakravarti A,Noll E,Black PM,et al.Quantitatively determined survivin expression levels are of prognostic value in human gliomas.J Clin Oncol,2002,20:1063-1068.
[9] Pennington BE,Leffell DJ.Mobs micrographic surgery:established uses and emerging trends.Oncology (Williston Park),2005,19:1165-1171.
[10] Bernier J.Alteration of radiotherapy fractionation and concurrent chemotherapy:a new frontier in head and neck oncology? Nat Clin Pract Oncol,2005,2:305-314.
[11] Salvati M,Caroli E,Paone C,et al.Brain metastasis from cutaneous squamous cell carcinoma of the dorsum.Case report.J Neurosurg,2005,102:1155-1158.
[12] Miller DW,Vosseler S,Mirancea N,et al.Rapid vessel regression,protease inhibition,and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants.Am J Pathol,2005,167:1389-1403.
[13] Chen Z,Smith KJ,Skelton HG 3rd,et al.Telomerase activity in Kaposi's sarcoma,squamous cell carcinoma,and basal cell carcinoma.Exp Biol Med (Maywood),2001,226:753-757.
[14] Miller HI.Gene therapy on trial.Science,2000,287:591-592.
[15] Krutmann J.Ultraviolet A radiation-induced biological effects in human skin:relevance for photoaging and photodermatosis.J Dermatol Sci,2000,23(Suppl 1):S22-26.
[16] Dhanalakshmi S,Mallikarjuna GU,Singh RP,et al.Dual efficacy of silibinin in protecting or enhancing ultraviolet B radiation-caused apoptosis in HaCaT human immortalized keratinocytes.Carcinogenesis,2004,25:99-106.

��е��

1��ŵ´�,�Ľ��,��.��Խǻ��෢��״ϸ��һ��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(1): 5-

2��÷��,��,��,.��״��һ��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(3): 148-148

3��,��,.E-��𤵰��Ƥ��״ϸ��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(1): 30-32

4��ܺ��,��ط�,�˵�Ȩ.��ٰ�һ��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(2): 72-73

5��֮�� .Notch�ź�ͨ·��Ƥ��о��״[J]. ��Ƥ��Բ�ѧ��־, 2009,35(5): 330-332

6�� Ȩ �� .��KID�ۺ��״ϸ��ë��[J]. ��Ƥ��Բ�ѧ��־, 2009,35(5): 271-272

7��ջݴ� �̲� ʩ�� ۳��.��Դ��Ա�Ƥ�ɽ�֢�鹬��״ϸ��һ��[J]. ��Ƥ��Բ�ѧ��־, 2010,36(2): 66-68

8�� .��״��Ǵ��̷��ͷֻ��״ϸ��һ��[J]. ��Ƥ��Բ�ѧ��־, 2010,36(3): 177-177

9��ⳣϼ �� .ͷ�沿Ѫ��ҷ��״ϸ��һ��[J]. ��Ƥ��Բ�ѧ��־, 2010,36(6): 356-356

10��ٻ� ֣��.Ĥ��A2�ṹ��ܼ��Ƥ��ϵ��о��չ[J]. ��Ƥ��Բ�ѧ��־, 2011,37(1): 23-25

11��tȺ �� ⽨�� ｨ��.΢��׸��һ��[J]. ��Ƥ��Բ�ѧ��־, 2011,37(3): 132-134